Analytical Platform for Rapid, Reliable mRNA Modality Analytics, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into rapid, reliable analytics for evolving mRNA modalities. Attendees will learn about mRNA modality-specific CQA and analytics requirements. The featured speakers will share insights into the design and implementation of a modular analytical platforms for rapid deployment across varying mRNA programs.

TORONTO, Aug. 27, 2025 /PRNewswire/ -- The rapid evolution of messenger RNA (mRNA) based therapies and vaccines demands analytical workflows that are both highly reliable and adaptable to diverse modality-specific requirements. As vaccine constructs and therapeutic transcripts diversify in size, structure and lipid nanoparticle formulations, there is a growing need for an analytic platform that delivers consistent, high‐quality data without sacrificing agility. Traditional assay pipelines often struggle to balance throughput, sensitivity and flexibility, leading to delays in development timelines and potential gaps in quality control.

This webinar will examine the design and implementation of a modular analytical platform engineered for rapid deployment across varying mRNA applications, from prophylactic vaccine candidates to long-acting therapeutic constructs. The featured speakers will highlight how the platform is not only customizable but also accelerates early-stage screening and process optimization. Additionally, the platform supports scalable, regulatory-compliant analytics as candidates advance toward clinical and commercial phases. The assay parameters can be tailored to meet the specific demands of vaccines, transient therapeutics or long‐duration mRNA constructs.

Overall, this adaptable approach accelerates the development and validation process by streamlining assay deployment and reducing setup time. As the field of mRNA therapeutics continues to expand, a robust and flexible analytical platform will be essential for translating innovative modalities into safe, effective products that reach patients more quickly.

Register for this webinar to learn how a flexible analytical platform supports rapid, reliable analytics for evolving mRNA modalities.

Join experts from BA Sciences, Jeff Heiser, CSO of Microbial and Advanced Therapeutic Platforms; and Alaknanda Mishra, PhD, Director of Advanced Therapeutics, for the live webinar on Monday, September 15, 2025, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Analytical Platform for Rapid, Reliable mRNA Modality Analytics.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/analytical-platform-for-rapid-reliable-mrna-modality-analytics-upcoming-webinar-hosted-by-xtalks-302539357.html

SOURCE Xtalks